Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters

Therapeutic Methods and Therapies TCIM
Database
Language
Affiliation country
Publication year range
1.
Physiol Rep ; 6(5)2018 03.
Article in English | MEDLINE | ID: mdl-29536649

ABSTRACT

In the first case, the AA and glucose were infused through a perinatal port system into the umbilical vein at 30 weeks' gestation due to severe IUGR. The patient received daily hyperbaric oxygenation (HBO, 100% O2 ) with 1.4 atmospheres absolute for 50 min for 7 days. At 31+4  weeks' gestation, the patient gave birth spontaneously to a newborn weighing 1378 g, pH 7.33, APGAR score 4/6/intubation. In follow-up examinations at 5 years of age, the boy was doing well without any neurological disturbance or developmental delay. In the second case, the patient presented at 25/5  weeks' gestation suffering from severe IUGR received HBO and maternal AA infusions. The cardiotocography was monitored continuously during HBO treatment. The short-time variations improved during HBO from 2.9 to 9 msec. The patient developed pathologic CTG and uterine contractions 1 day later and gave birth to a hypotrophic newborn weighing 420 g. After initial adequate stabilization, the extremely preterm newborn unfortunately died 6 days later. Fetal nutrition combined with HBO is technically possible and may allow the prolongation of the pregnancy. Fetal-specific amino-acid composition would facilitate the treatment options of IUGR fetuses and extremely preterm newborn.


Subject(s)
Amino Acids/therapeutic use , Fetal Growth Retardation/therapy , Glucose/therapeutic use , Hyperbaric Oxygenation/methods , Placental Insufficiency/therapy , Adult , Amino Acids/administration & dosage , Female , Fetal Growth Retardation/drug therapy , Fetal Growth Retardation/pathology , Glucose/administration & dosage , Humans , Placental Insufficiency/drug therapy , Placental Insufficiency/pathology , Pregnancy
2.
Strahlenther Onkol ; 192(3): 174-81, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26501141

ABSTRACT

BACKGROUND: Inspiratory hyperoxia under hyperbaric conditions has been shown to effectively reduce tumor hypoxia and to improve radiosensitivity. However, applying irradiation (RT) under hyperbaric conditions is technically difficult in the clinical setting since RT after decompression may be effective only if tumor pO2 remains elevated for a certain period of time. The aim of the present study was to analyze the time course of tumor oxygenation and perfusion during and after hyperbaric hyperoxia. MATERIALS AND METHODS: Tumor oxygenation, red blood cell (RBC) flux for perfusion monitoring, and vascular resistance were assessed continuously in experimental rat DS-sarcomas by polarographic catheter electrodes and laser Doppler flowmetry at 1 and 2 atm (bar) of environmental pressure during breathing of pure O2 or carbogen (95 % O2 + 5 % CO2). RESULTS: During room air breathing, the tumor pO2 followed very rapidly within a few minutes the change of the ambient pressure during compression or decompression. With O2 breathing under hyperbaric conditions, the tumor pO2 increased more than expected based on the rise of the environmental pressure, although the time course was comparably rapid. Breathing carbogen, the tumor pO2 followed with a slight delay of the pressure change, and within 10 min after decompression the baseline values were reached again. RBC flux increased during carbogen breathing but remained almost constant with pure O2, indicating a vasodilation (decrease in vascular resistance) with carbogen but a vasoconstriction (increase in vascular resistance) with O2 during hyperbaric conditions. CONCLUSION: Since the tumor pO2 directly followed the environmental pressure, teletherapy after hyperbaric conditions does not seem to be promising as the pO2 reaches baseline values again within 5-10 min after decompression.


Subject(s)
Hyperbaric Oxygenation/methods , Inhalation , Neovascularization, Pathologic/physiopathology , Oxygen Consumption , Oxygen/metabolism , Sarcoma/physiopathology , Animals , Blood Flow Velocity , Male , Metabolic Clearance Rate , Oxidative Stress , Rats , Rats, Sprague-Dawley , Sarcoma/blood supply
3.
Strahlenther Onkol ; 191(11): 875-82, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26135917

ABSTRACT

BACKGROUND: Inspiratory hyperoxia reduces tumor hypoxia, which is responsible for limited radiosensitivity of tumors. However, very little is known about the heterogeneity of intratumoral oxygenation during this supportive treatment. The study analyzes whether local hypoxia is still present during normobaric and hyperbaric inspiratory hyperoxia and whether the addition of CO2 to the inspiratory gas affects the spatial pO2 distribution. MATERIAL AND METHODS: Tumor oxygenation of experimental DS-sarcomas in rats was assessed by polarographic needle electrodes at 1 and 2 atm (bar) environmental pressure during pure O2 or carbogen (95 % O2 + 5 % CO2) breathing. Up to 320 individual pO2 measurements were performed in a strictly oriented grid resulting in an oxygenation profile in a horizontal tumor layer. RESULTS: In the experimental tumors used the oxygenation showed pronounced heterogeneities with closely adjacent hypoxic and oxygenated regions. This heterogeneity was still visible under normobaric hyperoxia where large confluent hypoxic regions were detectable. At 1 atm, the addition of CO2 improved tumor oxygenation significantly (at least in large tumors). At 2 atm, only very small local regions of hypoxia were detected. However, under this condition hypercapnia had no impact on tumor oxygenation. CONCLUSIONS: The data show that even under hyperbaric hyperoxia, hypoxic regions are detectable despite the average pO2 increased by a factor of 100. The results also clearly indicate that the oxygenation pattern improves disproportionally with increasing environmental pressure.


Subject(s)
Carcinosarcoma/metabolism , Carcinosarcoma/therapy , Hyperbaric Oxygenation/methods , Oxygen Consumption , Oxygen/metabolism , Animals , Male , Rats , Rats, Sprague-Dawley , Tissue Distribution
4.
Adv Exp Med Biol ; 530: 237-47, 2003.
Article in English | MEDLINE | ID: mdl-14562721

ABSTRACT

Since local hyperthermia (HT) affects microenvironmental parameters, the aim of the study was to analyze the impact of 42 degrees C-HT on microcirculatory function, tumor pO2, microregional redox status and ATP distribution in experimental rat tumors. Subcutaneously growing DS-sarcomas were treated with localized HT using infrared-A radiation resulting in a mean tumor temperature of 42 degrees C. The relative red blood cell (RBC) flux in the tumor was assessed using the laser Doppler technique and the mean tumor pO2 measured continuously using O2-sensitive catheter electrodes. In a second series of experiments, the microregional distribution of the mitochondrial redox status and ATP concentration was measured. Although the average RBC flux increased by 63%, tumor pO2 rose only by approx. 6%. No distinct changes were seen in the mitochondrial redox status. The microregional distribution of the redox status as well as of the ATP concentration showed considerable heterogeneity. In conclusion, although 42 degrees C-HT leads to a distinct improvement in tumor perfusion, there is practically no change in the oxygenation status. The latter finding can be explained by an equivalent increase in the oxygen consumption rate of the cells which increases by approx. 58% at 42 degrees C compared to normothermia.


Subject(s)
Adenosine Triphosphate/metabolism , Hyperthermia, Induced , Neoplasms, Experimental/metabolism , Oxygen/metabolism , Animals , Male , Oxidation-Reduction , Rats , Rats, Sprague-Dawley
5.
Int J Radiat Oncol Biol Phys ; 55(5): 1358-62, 2003 Apr 01.
Article in English | MEDLINE | ID: mdl-12654448

ABSTRACT

PURPOSE: The effect of recombinant human erythropoietin (rhEPO) on the radiosensitivity of human tumor xenografts growing in anemic and nonanemic nude mice was studied. METHODS AND MATERIALS: Anemia was induced by total body irradiation ([TBI], 2 x 4 Gy) of mice before tumor implantation into the subcutis of the hind leg. The development of anemia was prevented by rhEPO (750 U/kg s.c.) given 3 times weekly starting 2 weeks before TBI. Fourteen days after fractionated TBI (tumor volume of approx. 40 mm(3)), single-dose irradiation of the tumor with varying doses was performed so that in full dose-response relationship for the probability of tumor cure was obtained. RESULTS: Radiation-induced anemia (hemoglobin concentration [cHb] = 9.9 g/dl) led to a reduced radiosensitivity compared to controls [49.4 vs. 40.1 Gy radiation dose to control 50% of the tumors (TCD50)]. Upon rhEPO treatment for anemia prevention (cHb = 13.3 g/dl), the TCD50 was 39.8 Gy, illustrating restored radiosensitivity compared to anemic mice. CONCLUSION: These data provide further experimental evidence for restored radiosensitivity upon prevention of anemia with rhEPO.


Subject(s)
Anemia/drug therapy , Erythropoietin/pharmacology , Radiation Injuries, Experimental/drug therapy , Radiation Tolerance/drug effects , Sarcoma/radiotherapy , Whole-Body Irradiation , Anemia/complications , Anemia/metabolism , Animals , Cell Hypoxia , Dose Fractionation, Radiation , Drug Evaluation, Preclinical , Erythropoietin/therapeutic use , Hemoglobins/analysis , Humans , Mice , Mice, Nude , Neoplasm Transplantation , Radiation Injuries, Experimental/complications , Radiation Injuries, Experimental/metabolism , Recombinant Proteins , Sarcoma/complications , Sarcoma/metabolism , Transplantation, Heterologous , Whole-Body Irradiation/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL